Sarah Pringle

Court Square starts process for Medical Knowledge Group

The medical communications agency heads to market as several relevant companies recently fielded investment from firms including TPG, Ares Management, Water Street, JLL and GHO Capital.

Charlesbank expands healthcare bench, hiring former-Advent investor Bert Duarte

Charlesbank’s current umbrella of healthcare investments include MB2Dental, MyEyeDoctor and Tecomet.

TPG makes significant investment in BGB Group

TPG's investment values the medical communications agency at $760m, sources tell PE Hub, as growth in drug development spurs more demand for the industry's services.

Sixth Street injects $500m into Vista's MindBody amid ClassPass acquisition, MSD Partners builds out growth platform

MSD Partners taps co-head of growth while Vista's MindBody buys ClassPass.

Victor Hwang joins MSD Partners as co-head of newly-launched MSD Growth

Hwang joins from industry Ventures, and has previous experience at Internet Capital Group and Goldman Sachs.

Wellspring’s RAYUS adds Diagnostic Centers of America in national undertaking

The acquisition takes RAYUS to approximately $140m in EBITDA as it inherits eight new radiology centers and a new subspecialist partnership in South Florida.

PE-backed Eversana nears deal for Intouch; Kohlberg, Partners-backed PCI Pharma values LSNE at $1.5bn; OEP generates 5x return on PS Logistics

PE-backed Eversana nears deal for Intouch while OEP reaps 5x its money on PS Logistics.

Clearlake, Charlesbank-backed Symplr completes Halo Health acquisition

The acquisition amplifies the healthcare-focused governance, risk, and compliance SaaS platform's clinical communications and collaboration capabilities.

Kinderhook recapitalizes Coleman Powersports

As part of the transaction, several seasoned industry executives are joining the maker of powersports vehicles' board of directors: Todd Balan, Mark Hanley, Steve Hill and John Larson.

Kohlberg, Partners-backed PCI Pharma snags Permira's LSNE at $1.5bn valuation

The PE-backed CDMO grows its mix of work as it gains significant capabilities in lyophilization, an important manufacturing process commonly used in the fast-growing biologics market.